Skin Disease and Inflammation: Current Treatment and Future Options
A special issue of Therapeutics (ISSN 2813-9909).
Deadline for manuscript submissions: closed (10 October 2025) | Viewed by 952
Special Issue Editor
Interests: psoriasis; atopic dermatitis; idradenitis; biological treatment; acne
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Outstanding progress has been made in recent decades in dermatology, especially regarding inflammatory skin diseases, which are more common and tend to have a significant impact on patients' quality of life. Chronic inflammatory diseases represent a therapeutic challenge. Today, we have weapons available, as well as many new drugs in the pipeline for various conditions that had no therapy for years.
I would like to invite you to take part in this Special Issue for the journal of Therapeutics of which I am the editor.
The aim of this Special Issue is to publish scientific articles on a variety of topics, but above all, to focus on new therapies in the medical field, biological therapies, target therapies and innovative therapies with exciting data that can help the entire scientific community. The possibility of collecting all this in various publications is the purpose of this Special Issue.
I look forward to receiving your contributions and thank you for your support.
Dr. Annunziata Dattola
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Therapeutics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- eczema
- psoriasis
- hidradenitis suppurativa
- alopecia areata
- acne
- atopic dermatitis
- urticaria
- prurigo nodularis
- lichen
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
